The CELLTHEON SMART Platform has been used to date in 60+ biologics from oncology to neurobiology and RA programs, including five (5) biosimilars.
- 12-14 weeks to RCB
- High titers: 6-8g/L
- >120 gen. stability
- Scalable, commercial fed-batch platform
- Built in QbD
- Low metabolic waste
- No gene amplification
- No pool enrichment
- No automated colony selection equipment